| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/15/2023 | 50.77% | Cantor Fitzgerald | $59 → $49 | Maintains | Overweight |
| 09/26/2023 | 81.54% | Cantor Fitzgerald | → $59 | Reiterates | Overweight → Overweight |
| 08/22/2023 | 81.54% | Cantor Fitzgerald | → $59 | Reiterates | Overweight → Overweight |
| 08/17/2023 | 81.54% | Cantor Fitzgerald | → $59 | Reiterates | Overweight → Overweight |
| 06/30/2021 | 38.46% | Cantor Fitzgerald | → $45 | Initiates Coverage On | → Overweight |
What is the target price for Sanara MedTech (SMTI)?
The latest price target for Sanara MedTech (NASDAQ: SMTI) was reported by Cantor Fitzgerald on November 15, 2023. The analyst firm set a price target for $49.00 expecting SMTI to rise to within 12 months (a possible 50.77% upside). 4 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Sanara MedTech (SMTI)?
The latest analyst rating for Sanara MedTech (NASDAQ: SMTI) was provided by Cantor Fitzgerald, and Sanara MedTech maintained their overweight rating.
When is the next analyst rating going to be posted or updated for Sanara MedTech (SMTI)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Sanara MedTech, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Sanara MedTech was filed on November 15, 2023 so you should expect the next rating to be made available sometime around November 15, 2024.
Is the Analyst Rating Sanara MedTech (SMTI) correct?
While ratings are subjective and will change, the latest Sanara MedTech (SMTI) rating was a maintained with a price target of $59.00 to $49.00. The current price Sanara MedTech (SMTI) is trading at is $32.50, which is out of the analyst's predicted range.